HIF-1α and Bid in Colorectal Cancer
Author Information
Author(s): Seenath M M, Roberts D, Cawthorne C, Saunders M P, Armstrong G R, O'Dwyer S T, Stratford I J, Dive C, Renehan A G
Primary Institution: Christie Hospital NHS Foundation Trust, Manchester, UK
Hypothesis
HIF-1α represses bid transcription leading to reduced Bid expression in ex vivo colorectal cancer.
Conclusion
The study found that high levels of HIF-1α are associated with reduced expression of Bid in colorectal cancer tissues.
Supporting Evidence
- HIF-1α expression was present in all adenocarcinomas but varied within tumors.
- High HIF-1α levels correlated with low Bid expression.
- The study used robust staining controls and validated the paired same area serial analysis.
Takeaway
In colorectal cancer, when there's a lot of a protein called HIF-1α, another protein called Bid doesn't work as well, which might make it harder for cancer cells to die.
Methodology
The study used immunohistochemistry to assess HIF-1α and Bid expression in serial sections of colorectal adenocarcinomas.
Limitations
The study's findings may be influenced by the genetic heterogeneity of human tumors and the lack of a native stromal microenvironment in xenograft models.
Participant Demographics
Patients with colorectal adenocarcinoma from Manchester, UK.
Statistical Information
P-Value
0.04
Confidence Interval
95% CI: 0.67–0.88
Statistical Significance
p=0.04
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website